2021 annual financial data
Cullinan Therapeutics 2021 Operating cash flow margin
Cullinan Therapeutics 2021 operating cash flow margin with verified reported va…
Direct answer
Operating cash flow margin was -229.28%.
Operating income was -67,954,000 USD and net income was -65,040,000 USD.
Operating cash flow was -43,433,000 USD.
Get free Cullinan Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 18,943,000 USD
- Operating income
- -67,954,000 USD
- Net income
- -65,040,000 USD
- Operating cash flow
- -43,433,000 USD